DiaMedica Therapeutics Inc. (DMAC) Insider Trading

Name: DiaMedica Therapeutics Inc. (DMAC) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 12, 2026): Dietrich John Pauls (President & CEO): Grant/Award of 60,200 shares.

Get alerted when insiders trade DMAC

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta